The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance
Open accessAbstract
Importance: To our knowledge, there has been no update on the prevalence of chronic kidney disease (CKD) in China since 2012. Objective: To provide periodic nationwide data on the prevalence of CKD and the associated behavioral and metabolic risk factors in China. Design, Setting, and Participants: This nationally representative cross-sectional study included data from 176 874 adults from all 31 provincial-level administrative divisions in mainland China, as reported in the sixth China Chronic Disease and Risk Factor Surveillance conducted from August 2018 to June 2019. Data analysis was performed in 2021 to 2022. Exposures: Serum creatinine, urinal creatinine, and urine albumin were measured for all participants. Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine using the CKD-EPI equation. Main Outcomes and Measures: The primary outcome was weighted prevalence of CKD in the overall population and different strata, defined as presence of impaired kidney function (eGFR of <60 mL/min/1.73m 2) or albuminuria (urine albumin-to-creatinine ratio of ≥30 mg/g). Secondary outcomes were awareness of CKD and control of comorbidities. Logistic regression was used to examine the association of sociodemographic characteristics, behavioral and dietary habits, physical activity, and comorbidities with CKD. Results: A total of 184 876 participants contributed data to this study, and of the 176 874 adults 18 years and older with measurements of eGFR and urine albumin-to-creatinine ratio in 2018 to 2019, the mean age was 43.8 years and the weighted proportion of women was 44.6%. The estimated prevalence of CKD, impaired kidney function, and albuminuria were 8.2%, 2.2%, and 6.7%, respectively. A higher prevalence of CKD was observed in the subgroups characterized by older age, female gender, non-Han ethnicity, residency of rural or north and central parts of China, receiving less education or lower income, former smoking, no alcohol drinking, lacking physical activity, and presence of risk factors such as obesity, hypertension, diabetes, dyslipidemia, and self-reported cardiovascular disease. Among the adults with CKD, 73.3%, 25.0%, and 1.8% were at stage 1 to 2, 3, and 4 to 5, respectively, and the awareness of CKD was 10.0%. Conclusions and Relevance: This cross-sectional study found a weighted estimated of 82 million adults with CKD in China in 2018 to 2019. The prevalence appears to have decreased by 30% in the past decade. Better environmental protection, integration of CKD into the national public health surveillance program, and control of common CKD comorbidities appear to be associated with reducing the disease burden of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
Stevens, P. E., Levin, A., & for the Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00007 · Cited by 3,607
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
Prevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Prevalence of chronic kidney disease in China: a cross-sectional survey
Zhang, L., Wang, F., Wang, L., Wang, W., Liu, B., Liu, J., Chen, M., He, Q., Liao, Y., Yu, X., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60033-6 · Cited by 2,091
Self-citationLi, Y., Teng, D., Shi, X., Qin, G., Qin, Y., Quan, H., Shi, B., Sun, H., Ba, J., Chen, B., et al. (2020) · BMJ · doi:10.1136/bmj.m997 · Cited by 1,580
Prevalence and Treatment of Diabetes in China, 2013-2018
Wang, L., Peng, W., Zhao, Z., Zhang, M., Shi, Z., Song, Z., Zhang, X., Li, C., Huang, Z., Sun, X., et al. (2021) · JAMA · doi:10.1001/jama.2021.22208 · Cited by 961
Self-citationTrends in Chronic Kidney Disease in China
Zhang, L., Long, J., Jiang, W., Shi, Y., He, X., Zhou, Z., Li, Y., Yeung, R. O., Wang, J., Matsushita, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602469 · Cited by 765
Trends in Prevalence of Chronic Kidney Disease in the United States
Murphy, D., McCulloch, C. E., Lin, F., Banerjee, T., Bragg-Gresham, J. L., Eberhardt, M. S., Morgenstern, H., Pavkov, M. E., Saran, R., Powe, N. R., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0273 · Cited by 616
Wang, L., Zhou, B., Zhao, Z., Yang, L., Zhang, M., Jiang, Y., Li, Y., Zhou, M., Wang, L., Huang, Z., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00798-4 · Cited by 585
Self-citationThe global burden of chronic kidney disease: estimates, variability and pitfalls
Glassock, R. J., Warnock, D. G., & Delanaye, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.163 · Cited by 511
Environmental pollution and kidney diseases
Xu, X., Nie, S., Ding, H., & Hou, F. F. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.11 · Cited by 501
Self-citationLong-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China
Xu, X., Wang, G., Chen, N., Lu, T., Nie, S., Xu, G., Zhang, P., Luo, Y., Wang, Y., Wang, X., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010093 · Cited by 476
Self-citationWang, J., Zhang, L., Wang, F., Liu, L., Wang;, H., & the China National Survey of Chronic Kidney Disease Working Group (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu053 · Cited by 384
CKD: A Call for an Age-Adapted Definition
Delanaye, P., Jager, K. J., Bökenkamp, A., Christensson, A., Dubourg, L., Eriksen, B. O., Gaillard, F., Gambaro, G., van der Giet, M., Glassock, R. J., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019030238 · Cited by 357
Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD
Bowe, B., Xie, Y., Li, T., Yan, Y., Xian, H., & Al-Aly, Z. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030253 · Cited by 354
Arora, P., Vasa, P., Brenner, D., Iglar, K., McFarlane, P., Morrison, H., & Badawi, A. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.120833 · Cited by 346
Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis
Kelly, J. T., Su, G., Zhang, L., Qin, X., Marshall, S., González-Ortiz, A., Clase, C. M., Campbell, K. L., Xu, H., & Carrero, J.-J. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030384 · Cited by 317
Xia, J., Wang, L., Ma, Z., Zhong, L., Wang, Y., Gao, Y., He, L., & Su, X. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw452 · Cited by 285
Self-citationWhite, S. L., Polkinghorne, K. R., Atkins, R. C., & Chadban, S. J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.011 · Cited by 272
Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China
Li, G., Huang, J., Wang, J., Zhao, M., Liu, Y., Guo, X., Wu, S., & Zhang, L. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040517 · Cited by 124
Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD
Blum, M. F., Surapaneni, A., Stewart, J. D., Liao, D., Yanosky, J. D., Whitsel, E. A., Power, M. C., & Grams, M. E. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08350719 · Cited by 116
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report
Yang, C., Gao, B., Zhao, X., Su, Z., Sun, X., Wang, H., Zhang, P., Wang, R., Liu, J., Tang, W., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.09.003 · Cited by 108
Accuracy of GFR estimation in obese patients.
Lemoine, S., Guebre-Egziabher, F., Sens, F., Nguyen-Tu, M.-S., Juillard, L., Dubourg, L., & Hadj-Aissa, A. (2014) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.03610413 · Cited by 103
Data Resource Profile: China Chronic Disease and Risk Factor Surveillance (CCDRFS)
Zhang, M., Wang, L., Wu, J., Huang, Z., Zhao, Z., Zhang, X., Li, C., Zhou, M., & Wang, L. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab255 · Cited by 66
Self-citationLee, S., Kim, Y. C., Oh, S., Koo, H., Na, K. Y., Chae, D., Kim, S., & Chin, H. J. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr154 · Cited by 46
Bottomley, M. J., Kalachik, A., Mevada, C., Brook, M. O., James, T. J., & Harden, P. (2010) · Nephron Clinical Practice · doi:10.1159/000321515 · Cited by 29
[Scheme of the Chinese chronic non-communicable disease and risk factor surveillance].
Wang, L. M., Zhang, M., Li, Y. C., et al. (2018) · PubMed · doi:10.3760/cma.j.issn.0253-9624.2018.02.015 · Cited by 24
Self-citation
Metadata
- Authors
- Wang, L., Xu, X., Zhang, M., Hu, C., Zhang, X., Li, C., Nie, S., Huang, Z., Zhao, Z., Hou, F. F., & Zhou, M.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2023-04-01
- Volume
- 183
- Issue
- 4
- Pages
- 298
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W4321370754
- Cited by
- 568
- References
- 29
- FWCI
- 93.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.